The Cigna Group (CI) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
22 Apr, 2026Opening remarks and agenda
The meeting was opened by the Chair and CEO, with the Board of Directors and Enterprise Leadership Team present.
The agenda and rules of conduct were posted on the meeting website, and participants were asked to abide by them.
Financial performance review
Full-year total revenue for 2025 reached $275 billion, up 11% year-over-year.
Shareholders' net income was $6 billion ($22.18 per share), and adjusted income from operations was $8 billion ($29.84 per share).
Cash flow from operations totaled $9.8 billion, with $5.2 billion returned to shareholders via dividends and share repurchases.
A $3.5 billion investment in Shields Health Solutions and the $4.9 billion sale of the Medicare business were completed in 2025.
Board and executive committee updates
The CEO announced his retirement effective July 1, transitioning to Executive Chair, with the current President and COO succeeding as CEO.
Latest events from The Cigna Group
- 2024 revenue up 27% to $247.1B; 2025 outlook strong with higher EPS and capital returns.CI
Q4 20249 Jul 2026 - Specialty drug innovation and biosimilars drive rapid growth and cost savings in healthcare.CI
Bernstein Healthcare 1:1 Forum 20249 Jul 2026 - Q3 2024 revenue up 30% to $63.7B, EPS up 11%, net income down on VillageMD loss.CI
Q3 20248 Jul 2026 - Q2 2025 revenue up 11% to $67.2B, adjusted EPS $7.20, and EPS guidance reaffirmed at $29.60+.CI
Q2 20258 Jul 2026 - Rebate-free PBM model scales by 2028; specialty and AI drive growth and efficiency.CI
Bank of America Global Healthcare Conference 202613 May 2026 - Q1 2026 saw higher revenues, profits, and a raised outlook, driven by strong segment results.CI
Q1 20269 May 2026 - Board recommends approval of all annual meeting items except the written consent proposal.CI
Proxy Filing13 Mar 2026 - Strong 2025 results, portfolio focus, and leadership transition headline this year’s proxy.CI
Proxy Filing13 Mar 2026 - Rebate-free PBM model and specialty pharmacy expansion drive growth and transparency.CI
TD Cowen 46th Annual Health Care Conference2 Mar 2026